Characteristics, treatment patterns, prognostic determinants and outcome of peripheral T cell lymphoma and natural killer/T cell non-Hodgkin Lymphoma in older patients: The result of the nationwide multi-institutional registry Thai Lymphoma Study Group-Reference-Cited by-同舟云学术

Characteristics, treatment patterns, prognostic determinants and outcome of peripheral T cell lymphoma and natural killer/T cell non-Hodgkin Lymphoma in older patients: The result of the nationwide multi-institutional registry Thai Lymphoma Study Group

Published:2020-01 Issue:1 Volume:11 Page:62-68
ISSN:1879-4068
Container-title:Journal of Geriatric Oncology
language:en
Short-container-title:Journal of Geriatric Oncology

Author:

Wudhikarn Kitsada,Bunworasate Udomsak,Julamanee Jakrawadee,Lekhakula Arnuparp,Ekwattanakit Supachai^ORCID,Khuhapinant Archrob,Chuncharunee Suporn,Niparuck Pimjai,Numbenjapon Tontanai,Prayongratana Kannadit,Kanitsap Nonglak,Wongkhantee Somchai,Makruasi Nisa,Wong Peerapon,Norasetthada Lalita^ORCID,Nawarawong Weerasak,Sirijerachai Chittima,Chansung Kanchana,Suwanban Tawatchai,Praditsuktavorn Pannee,Intragumtornchai Tanin

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Oncology

Reference25 articles.

1. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes;Vose;J Clin Oncol,2008

2. Epidemiology of Lymphoid Malignancy in Asia;Mozaheb,2012

3. T-cell lymphoma epidemiology: the known and unknown;Phan;Curr Hematol Malig Rep,2016

4. Peripheral T cell lymphoma in Asia;Park;Int J Hematol,2014

5. Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group;Schmitz;Blood.,2010

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Up-front Therapy With CHOP Plus Etoposide in Brazilian nodal PTCL Patients: Increased Toxicity and No Survival Benefit Compared to CHOP Regimen–Results of a Real-Life Study From a Middle-Income Country;Clinical Lymphoma Myeloma and Leukemia;2022-11

2. How to Sequence Therapies in Peripheral T Cell Lymphoma;Current Treatment Options in Oncology;2021-07-02

3. The Value and Relevance of T‐cell Lymphoma Registries;The Peripheral T‐Cell Lymphomas;2021-02-19

4. All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma;Cancer Chemotherapy and Pharmacology;2020-10-18

5. Controversies in the Treatment of Peripheral T-cell Lymphoma;HemaSphere;2020-09-01